Table 2.

Clinical Characteristics of Patients Requiring LT During the First Year of Treatment

Patient Number	Clinical Presentation	Treatment	Treatment Response	Months to LT	MELD at Diagnosis	MELD at LT
Acute AIH group
1	Cirrhosis	Prednisolone	Treatment failure	2	20	30
	Ascites	Azathioprine/mycophenolate mofetil*
	Encephalopathy after 4 weeks
AS‐AIH group
1	Acute liver failure	Prednisolone	Treatment failure	0.25	24	37
2	Cirrhosis	Prednisolone	Treatment failure	0.5	25	29
	Encephalopathy
	Ascites
3	Acute liver injury	Prednisolone	Treatment failure	1	24	44
4	Cirrhosis	Prednisolone	Treatment failure	3	27	24
	SBP	Azathioprine/mycophenolate mofetil †
	Ascites
5	Cirrhosis	Prednisolone	Treatment failure	8	16	15
	Encephalopathy	Cyclosporine
6	Cirrhosis	Prednisolone	Incomplete response	9	18	9
	Hepatopulmonary syndrome	Thioguanine

^*Azathioprine was replaced by mycophenolate mofetil due to insufficient treatment response.

^†Azathioprine was replaced by mycophenolate mofetil due to adverse effects related to the azathioprine.